Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD

Bayer, A. J., Wilkinson, D., Paterson, K. R., Jenkins, L., Bullock, R., Donoghue, S., Millais, S. B. and Jones, R. (2005) Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD. Neurology, 64 (1). pp. 94-101. ISSN 0028-3878

Full text not available from this repository

Publisher's URL: http://dx.doi.org/10.1212/01.WNL.0000148604.77591....


Item Type:Article
Uncontrolled Keywords:AN1792, Alzheimer's, dementia
Faculty/Department:Faculty of Health and Applied Sciences
ID Code:2651
Deposited By: H. Upload account
Deposited On:21 Jan 2010 13:09
Last Modified:14 Mar 2014 15:56

Request a change to this item

Copyright 2013 © UWE better together